Artur Widak | Nurphoto | Getty Images Moderna‘s latest Covid vaccine has shown promising results in combating the highly mutated omicron variant called BA.2.86, based on clinical trial data released by the biotech company on Wednesday. Health officials are closely monitoring this variant, and Moderna’s vaccine has demonstrated a strong immune response against it. According …
The Food and Drug Administration (FDA) has granted approval for a new vaccine developed by Pfizer to protect infants from respiratory syncytial virus (RSV), which is the leading cause of hospitalization among babies in the U.S. Pfizer’s RSV shot is already available for older adults. This vaccine is the second treatment approved by the FDA …
As we approach the fall and winter months, the U.S. is expecting a new wave of viral protection options for the public. This includes updated COVID-19 vaccines and new preventatives for the respiratory syncytial virus (RSV). These treatments will better equip the country to combat the respiratory viral season, during which the flu, COVID-19, and …
A pharmacist prepares to administer Covid-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center in Chicago, Illinois, Sept. 9, 2022. Scott Olson | Getty Images New Covid vaccines from Pfizer, Moderna, and Novavax are expected to provide protection against the new “Eris” variant, which …
Artur Widak | Nurphoto | Getty Images Moderna, the biotech company, witnessed a rise in its stock prices after revising its full-year outlook for its Covid vaccine, which is its only marketable product. This positive development comes even though the company reported a quarterly loss and a significant drop in revenue. During the second quarter, …
A Chicago CVS store pharmacist will be administering COVID-19 booster doses in the upcoming months. However, many Americans may not be willing to receive these booster shots due to pandemic fatigue, the belief that COVID-19 is no longer a concern, and confusion regarding personal risk levels. To combat this, public health officials and healthcare providers …
Pfizer announced on Wednesday that its experimental vaccine targeting Group B Streptococcus (GBS) has shown promising results in mid-stage clinical trials. GBS is a potentially deadly bacterial disease responsible for vaginal and urinary tract infections, as well as newborn infections like meningitis and septicemia. This vaccine, if approved, could be the world’s first shot to …
The Biden administration has called on Pfizer, Moderna, and Novavax to price their updated Covid vaccines at a “reasonable” rate when they become available in the US this fall. The US Department of Health and Human Services stressed that excessive pricing would exploit the trust placed in the manufacturers by the American people throughout the …
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The Biden administration unveiled a new initiative on Thursday to offer free Covid vaccines to uninsured Americans until December 2024, …
Respiratory syncytial virus vial. Manjurul | Istock | Getty Images The Centers for Disease Control and Prevention (CDC) has issued a recommendation for adults aged 60 and above to receive a single dose of RSV vaccines from Pfizer and GSK after consulting their doctors. The recommendation, which was made by an advisory panel of outside …